EPIC Program Annual Data Tables 2003-2004: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs^*

Rank by Number of Claims	Drug	Strength	Drug Type**	Number of Claims	EPIC Payments	Rank by Payment
Top 20 Totals				2,187,235	$157,073,626
Percent of Top 20 Drugs to Total Paid Claims				20.3%	22.6%
1	FUROSEMIDE	40MG	Gen	177,545	$805,548	167
2	LIPITOR	10MG	SS	169,555	$16,417,321	3
3	FOSAMAX	70MG	SS	157,348	$14,976,376	4
4	PLAVIX	75MG	SS	142,603	$24,139,333	1
5	METOPROLOL TARTRATE	50MG	Gen	140,755	$749,819	184
6	HYDROCHLOROTHIAZIDE	25MG	Gen	128,494	$449,071	271
7	NORVASC	5MG	SS	128,481	$7,740,313	12
8	FUROSEMIDE	20MG	Gen	109,164	$445,419	273
9	ATENOLOL	50MG	Gen	104,197	$613,536	214
10	PROTONIX	40MG	SS	99,061	$13,430,813	8
11	LIPITOR	20MG	SS	97,203	$14,303,227	6
12	TOPROL XL	50MG	SS	91,006	$2,527,985	49
13	NORVASC	10MG	SS	87,843	$7,033,642	14
14	CELEBREX	200MG	SS	87,296	$11,322,428	9
15	PREVACID	30MG	SS	85,308	$16,651,281	2
16	ATENOLOL	25MG	Gen	80,825	$610,992	215
17	XALATAN	0.005%	SS	76,379	$3,557,621	33
18	NEXIUM	40MG	SS	75,799	$14,890,074	5
19	METFORMIN HCL	500MG	Gen	74,716	$1,841,523	68
20	AMBIEN	10MG	SS	73,657	$4,567,304	25

^* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2003-September 30, 2004) as well as the percentage of the totals they represent for the year.

^** Drug Type values are Gen='Generic' and SS='Sole Source'.